NCT03316534View on ClinicalTrials.gov

Effect of Aspirin on Abacavir-induced Platelet Reactivity in HIV-infected Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 2, 2017

Primary Completion Date

April 30, 2017

Study Completion Date

October 12, 2017

Conditions
HIV-infected Patients
Interventions
DRUG

Aspirin

Aspirin (100 mg once a day)

All Listed Sponsors
lead

Azienda Ospedaliera di Perugia

OTHER

NCT03316534 - Effect of Aspirin on Abacavir-induced Platelet Reactivity in HIV-infected Patients | Biotech Hunter | Biotech Hunter